Discovering New Drugs and Delivery Systems For Hearing Loss

Audion Therapeutics is a private biopharmaceutical company dedicated to the discovery, development and commercialization of drugs and delivery technologies for the treatment of diseases affecting the ear, including hearing loss.

Our mission is to improve the lives of patients suffering from the most prevalent forms of hearing loss including associated with aging, excessive noise or exposure to ototoxic drugs. Today, about 250 million people suffer from moderate-to-severe or greater hearing loss and this figure doubles when mild hearing loss is included. Yet no drug treatments currently exist.

We are committed to discovering highly effective disease-intervention therapies through our world-leading research into inner ear cellular biology and physiology, and selected partnerships.

About Us


Audion is focused on developing and partnering its intellectual property portfolio which includes biological assays, molecules and a drug discovery platform from the Massachusetts Eye and Ear Infirmary (MEEI).

[+] read more

Audion Drug Discovery


Our first small molecule drug discovery program is focused on regenerating lost inner ear hair cells, the main cause of the majority of hearing loss. We are also developing better ways to deliver these new drugs directly into the ear.

[+] read more

About Hearing Loss


Over 90% of hearing loss is due to damage to the hair cells or auditory neurons in the cochlea. The most important causes are ageing, excessive noise or drugs whose side effects include hearing loss.

[+] read more

© Copyright Audion Therapeutics 2011. All rights reserved.